Robotic-assisted (MAKO) Versus Manual Total Knee Arthroplasty for Knee Osteoarthritis
Single-center, Randomized, Controlled, Double Blinded, 24-month Trial to Compare Robotic-assisted (MAKO) and Manual Total Knee Arthroplasty for Primary Osteoarthritis With 10 Year Follow-up for Complications
1 other identifier
interventional
170
0 countries
N/A
Brief Summary
Background: Total knee arthroplasty is a golden standard procedure for end-stage knee osteoarthritis. However, up to 20% of the patients are not satisfied with the outcome. Recently, robotic-assisted TKAs have been developed to offer individual alignment and to achieve accuracy in positioning with more subtle soft-tissue handling, thus possibly leading into better outcome. Hypothesis: The investigators hypnotize that, robotic-assisted TKA is superior to manual TKA for end-stage osteoarthritis in respect to functional outcome, short-term rehabilitation and cost-efficiency. Trial desing: The investigators will conduct a single-center, randomized, controlled, double blinded superiority trial of 24-months to compare robotic-assisted and manual total knee arthroplasty in respect to functional outcome, implant positioning, short-term rehabilitation and cost-efficiency with up to 10 years follow-up for complications. The principle outcome measure will be patient reported outcome measure (PROM) Oxford knee score (OKS) points (0-48 points) at two years after surgery. Minimal clinically important difference will be considered as 5 points. Other PROMS, patient satisfaction, short-term rehabilitation, implant positioning, knee range of motion, length of sick leave and cost efficiency will also be reported. Patients will be followed up to 10 years for complications (infection, manipulation and revisions). This study will be conducted in Central Hospital of Satakunta (Satasairaala), Finland. The investigators will recruit 170 adult patients (aged 50-80), with end-stage (Kellgren-Lawrence grade IV) primary osteoarhritis. Patients will be randomly assingned to either robotic-assisted or manual TKA. Patients will be blinded by the intervention method used. Personnel and investigators assessing the patients and interpreting the data will also be blinded to the surgical method.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2025
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 28, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedFirst Posted
Study publicly available on registry
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2037
October 1, 2025
May 1, 2025
3.8 years
August 28, 2025
September 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Oxford Knee score OKS at 24 months
Patient reported outcome measure, knee function questionnaire Oxford Knee Score (OKS) at 24 month. Scale from 0 (=worst) to 48 (=excellent) points Minimal clinically important difference considered as 5 points.
24 month
Secondary Outcomes (27)
Oxford Knee Score at 3 and 12 months
3 and 12 months visits
Knee injury and Osteoarthritis Outcome Score (KOOS) at 3, 12 and 24 months
3, 12 and 24 months
The Western Ontario and McMaster Universities Arthritis Index (WOMAC) at 3, 12 and 24 months.
3, 12 and 24 months
Patient satisfaction inquiry at 3, 12 and 24 months
3, 12 and 24 months
Working ability, lenght of the sick leave
up to 24 months
- +22 more secondary outcomes
Study Arms (2)
Robotic-assisted total knee arthroplasty
EXPERIMENTALThe intervention group will undergo MAKO assisted RATKA. The patients will have individualized alignment. Knee balance is achieved with bony cuts and implant positioning, to avoid soft tissue releases. A preoperative planning based on computed tomography (CT) scans is made and intraoperatively computer assisted gap balancing is performed based on the plan and patient's soft tissue envelope and native joint line. The precise pre-operative planning, balancing and alignment method has been described by Calliess T el al.
Manual total knee arthroplasty
ACTIVE COMPARATORThe control group will undergo manual jig-guided TKA, with bony cuts made to achieve neutral mechanical axis, and if necessary, knee balancing will be performed by soft tissue releases. Weight bearing semi-flexion radiographs and long leg radiographs are used for preoperative planning. Intramedullary guiding rod is used in femur to align the cuts in 6 to 7 degrees of valgus. Femoral component rotation is fixed to trans-epicondylar line. Tibia cuts are aligned with either intra- or extramedullary guiding rod according to the preference of the surgeon. Tibia component rotation is fixed to medial one-third of tibial tubercle. After bony cuts, knee balancing is performed with soft-tissue and ligament releases if necessary.
Interventions
In robotic-assisted total knee arthroplasty, the procedure is performed with the guidance of the robot according to CT-based plan.
In manual total knee arthroplasty, the procedure is performed with jig guides according to whole leg weight bearing x-ray planning.
Eligibility Criteria
You may qualify if:
- Age over 50 and below 80 years
- End-stage Kellgren-Lawrence grade IV KOA
- Failed conservative treatment
You may not qualify if:
- Post-traumatic knee osteoarthritis
- Rheumatoid arthritis
- Previous knee infections
- Previous knee surgery (other than diagnostic arthroscopy or meniscectomy)
- Knee range of motion within 15 to 100 degrees
- Mechanical axis over 15 degrees of varus or over 10 degrees of valgus
- Body mass index over 40 kg/m2
- Significant patellofemoral osteoarthritis (Kellgren-Lawrence grade III or IV)
- Diabetes treated with insulin
- Malignancy with ongoing treatment
- Systemic glukocorticosteroid or antimetabolite medication during the last 5 years
- Conditions that do not allow general anesthesia
- Patients' denial for operative treatment and/or participation in the trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Silja Voutilainen, MD, PhD
Helsinki University Central Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Docent, MD
Study Record Dates
First Submitted
August 28, 2025
First Posted
October 1, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
July 1, 2029
Study Completion (Estimated)
September 1, 2037
Last Updated
October 1, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share